1) simvastatin
辛伐他丁
1.
Effect of simvastatin on endothelial expression of VCAM-1 and MCP-1 in rat model of type 2 diabetes mellitus;
辛伐他丁对2型糖尿病大鼠血管内皮VCAM-1和MCP-1 mRNA和蛋白表达的影响
2.
Simvastatin on the effect of the concentrations of NO,ET& Tc in the ischemia cardiopathy with hypercholesterolemia;
辛伐他丁对缺血性心脏病伴原发性高胆固醇血症患者NO、ET、Tc浓度的影响
3.
Effect of Simvastatin on stent restenosis and in-stent neointimal hyperplasia;
辛伐他丁对支架新生内膜的作用
2) simvastatin
辛伐他汀
1.
Improved synthesis of simvastatin;
辛伐他汀的合成工艺改进
2.
Preparation of sustained-release dropping pills of simvastatin and its dissolution rate;
辛伐他汀缓释滴丸的制备及体外释放度考察
3) Simvastain
辛伐他汀
1.
Influence of Simvastain on insulin sensitivity of patients with acute coronary syndrome;
辛伐他汀对急性冠脉综合征患者胰岛素敏感性的影响
2.
Remodeling of Transient Outward Potassium Channel in Left Ventricle of Rabbits with Heart Failure and Intervention with Losartan and Simvastain;
心力衰竭家兔左室瞬间外向钾通道重构及氯沙坦和辛伐他汀干预研究
3.
Affection of TNF-a、IL-1 and BNP level and heart function on chronic congestive heart failure combination treated with Simvastain and Valsartan
辛伐他汀联合缬沙坦对慢性心力衰竭患者血清TNF-α、IL-1、BNP水平和心功能的影响
4) Simavastatin
辛伐他汀
1.
Effects of simavastatin on the endothelial function in patients with coronary heart disease;
辛伐他汀对冠心病患者血管内皮功能的影响
2.
Simavastatin with Zhimaishu for Treatment of Hyperlipidemia;
脂脉舒联合辛伐他汀治疗高脂血症的临床观察
3.
Experimental study of combining simavastatin with Zhimaishu(脂脉舒) in hyperlipidemia treatment;
脂脉舒结合辛伐他汀治疗高脂血症的实验研究
5) simvastatins
辛伐他汀
1.
Effect of simvastatins and estrogen combination on osteoblasts in rats;
辛伐他汀和雌激素联合对大鼠成骨细胞分化和矿化功能的影响
2.
Effect of simvastatins on differentiation and mineralization of bone marrow stromal cells in rats;
辛伐他汀对大鼠骨髓基质细胞分化和矿化功能的影响
6) Simvatatin
辛伐他汀
1.
Simvatatin induces apoptosis of glomerular mesaginal cells via up-regulation of Smac expression under high concentration of glucose
辛伐他汀通过上调Smac表达诱导高糖培养下肾小球系膜细胞的凋亡
2.
Simvatatin has a beneficial on decreasing serum MCP-1,hsCRP and alleviating inflammatory reaction in patients with ACS.
目的:探讨辛伐他汀对急性冠脉综合征(ACS)患者血清单核细胞趋化蛋白-1(MCP-1)、超敏C反应蛋白(hsCRP)的影响。
3.
Objective To compare the efficacy and safety between simvatatin and artovastatin in the treatment of primary hypercholesterolemia.
目的比较辛伐他汀和阿托伐他汀治疗原发性高胆固醇血症的疗效和安全性。
补充资料：辛伐他丁
分子式：C25H28O5
分子量：418.57
CAS号：79902-63-9
性质：白色结晶性粉末。含量：98.0-101.0%鉴别：阳性反应阳伐它汀：≤1.0%比旋度：+285°-+298°干燥失重：≤0.5%炽灼残渣滓：≤0.1%重金属：≤0.002%色谱纯度：主杂：≤0.4% 总杂：≤1.0%
制备方法：暂无
用途：具有降低胆固醇、低密度脂蛋白胆固醇和极低密度脂蛋白胆固醇的作用。
分子量：418.57
CAS号：79902-63-9
性质：白色结晶性粉末。含量：98.0-101.0%鉴别：阳性反应阳伐它汀：≤1.0%比旋度：+285°-+298°干燥失重：≤0.5%炽灼残渣滓：≤0.1%重金属：≤0.002%色谱纯度：主杂：≤0.4% 总杂：≤1.0%
制备方法：暂无
用途：具有降低胆固醇、低密度脂蛋白胆固醇和极低密度脂蛋白胆固醇的作用。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条